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In Brief
Nitric oxide (NO) is a gaseous
neurotransmitter whose intracellular
machinery is expressed at abundant
levels within the striatum. Historically,
NO’s role in striatal plasticity has been
controversial. Rafalovich et al. have
conducted a series of pharmacological
and optogenetic studies that reveal that
NO is unequivocally a mediator of striatal
depression.
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Experience-driven plasticity of glutamatergic synap-
ses on striatal spiny projection neurons (SPNs) is
thought to be essential to goal-directed behavior
and habit formation. One major form of striatal
plasticity, long-term depression (LTD), has long
appeared to be expressed only pre-synaptically.
Contrary to this view, nitric oxide (NO) generated by
striatal interneurons was found to induce a post-syn-
aptically expressed form of LTD at SPN glutamater-
gic synapses. This form of LTD was dependent on
signaling through guanylyl cyclase and protein ki-
nase G, both of which are abundantly expressed by
SPNs. NO-LTD was unaffected by local synaptic ac-
tivity or antagonism of endocannabinoid (eCb) and
dopamine receptors, all of which modulate canoni-
cal, pre-synaptic LTD. Moreover, NO signaling dis-
rupted induction of this canonical LTD by inhibiting
dendritic Ca2+ channels regulating eCb synthesis.
These results establish an interneuron-dependent,
heterosynaptic form of post-synaptic LTD that could
act to promote stability of the striatal network during
learning.INTRODUCTION
The striatum has long been implicated in learning goal-directed
behavior and habits (Balleine et al., 2007). This learning is
thought to reflect changes in the strength of glutamatergic syn-
apses that dictate the timing and pattern of activity of principal
spiny projection neurons (SPNs) (Gerfen and Surmeier, 2011).
In the dorsal striatum, axospinous glutamatergic synapses on
SPNs are formed primarily by cortical pyramidal neurons.
Long-term depression (LTD) of these synapses was initially
described over 20 years ago and has been extensively studied
(Calabresi et al., 1992; Centonze et al., 2001; Gerfen and Surme-
ier, 2011; Kreitzer and Malenka, 2008; Mathur and Lovinger,1336 Cell Reports 13, 1336–1342, November 17, 2015 ª2015 The Au2012). The best-characterized form of LTD is induced by post-
synaptic depolarization and activation of metabotropic gluta-
mate receptors and L-type Ca2+ channels, which trigger the
generation of endocannabinoids (eCbs) by SPNs; expression
of LTD is mediated by eCb activation of pre-synaptic CB1 recep-
tors, which results in sustained depression of glutamate release
(Kreitzer and Malenka, 2005; Lovinger et al., 1993). Although
other neuromodulators can mimic the actions of eCbs at these
synapses (Mathur et al., 2011), no post-synaptically expressed
form of LTD has been described in SPNs.
One of the signaling molecules implicated in post-synaptically
expressed LTD elsewhere in the brain is NO (Garthwaite, 2008).
Striatal expression of NO signaling proteins soluble guanylyl
cyclase (sGC) and protein kinase G (PKG) are among the highest
of any brain region, making a role for NO signaling in striatal plas-
ticity plausible (Ariano, 1983; Ding et al., 2004). Indeed, NO has
been implicated in striatal synaptic plasticity, but its role is
controversial (Calabresi et al., 1999; Sammut et al., 2007), with
most of the available data suggesting it is a permissivemodulator
of eCb-dependent LTD (eCb-LTD) (Centonze et al., 1999, 2001).RESULTS
NO Signaling Produced LTD of Glutamatergic Synapses
To assess the potential role of NO signaling in striatal synaptic
plasticity, excitatory post-synaptic currents (EPSCs) evoked in
SPNs by electrical stimulation of corticostriatal axons were
monitored before, during, and after the application of the NO
donor (S)-nitroso-N-acetyl-D,L-penicillamine (SNAP, 100 mM) to
ex vivo parasagittal brain slices of mouse forebrain (Figure 1A).
In this preparation, cortical axons can be stimulated electrically
without directly activatingstriatal neurons, unlike thecoronal brain
slice (Kawaguchi et al., 1989). Transient application of SNAP led
to a persistent depression of corticostriatal EPSCs (Figure 1B).
To verify that our electrical stimulus was not directly exciting
SPNs, cortical pyramidal neurons were optogenetically activated
to evoke EPSCs; SNAP application also produced a persistent
depressionof optically evokedcorticostriatal EPSCs (FigureS1A).
NO can have both direct and indirect effects on proteins
involved in synaptic transmission (Garthwaite, 2008). Becausethors
Figure 1. NO Induces LTD at Corticostriatal Synapses through Activation of PKG
(A) Simplified diagram depicting the circuit components being examined.
(B) Sample whole-cell recording of an SPN before, during, and after a 10-min application of the NO donor SNAP (100 mM). Open circles represent single EPSC
events, and the solid line represents average EPSC size over a 1-min interval. EPSC amplitudes are normalized to baseline responses. Access resistance is
plotted below. Example EPSCs from this SPN are shown to the right before (pre-i, min 1–5 averaged) and after (post-i, min 30–35 averaged) SNAP application. The
stimulus artifact has been suppressed for clarity.
(C) PKG inhibition (3 mM, Rp-8-Br-PET-cGMPS, Rp8Br; black trace) blocked SNAP-induced LTD (red trace) (control: n = 14 cells; PKG inhibitor: n = 6). *p < 0.05,
signed rank test.
(D) Cartoon diagram illustrating the NO signaling cascade.
(E) Bath application of 8-Br-cGMP (500 mM) induced LTD in dSPNs (n = 7). *p < 0.05, signed rank test. Example EPSCs are shown to the right.
(F) 8-Br-cGMP induced LTD similarly in iSPNs and dSPNs (dSPNs, from E: n = 7; iSPN: n = 9). *p < 0.05, rank sum test. Data are presented as median, first and
third quartiles, and minimum and maximum of the data (whiskers).
(G) SNAP-induced LTD was unaffected by the inclusion of mecamylamine (10 mM) and scopolamine (10 mM) in the bath (n = 5). *p < 0.05, signed rank test.
(C, E, and G) Population data are presented as median and first and third quartiles.
Scale bars (vertical, horizontal) represent 10 pA, 20 ms (B) and 25 pA, 20 ms (E).its striatal expression is robust (Ariano, 1983), our working
hypothesis was that the NO donor effects were mediated by sol-
uble GC (sGC) activation. NO stimulates sGC, increasing cyto-
plasmic cyclic guanosine monophosphate (cGMP) production
and the activation of PKG (Figure 1D). If NO was acting through
this signaling cascade, its effects should be mimicked by ana-
logs of cGMP and blocked by inhibitors of PKG. Indeed, antag-
onism of PKG by including Rp-8-Br-PET-cGMPS (3 mM) in the
patch pipette blocked the effects of SNAP (Figure 1C), and brief
bath application of the membrane-permeable cGMP analog
8-bromo-cGMP (8Br-cGMP, 500 mM) produced a robustCell Repand persistent depression of corticostriatal EPSCs, mimicking
SNAP (Figure 1E). Moreover, the ability of SNAP to decrease
EPSC amplitudes was occluded in cells that had been pre-incu-
bated in 8Br-cGMP (Figure S1B). The effects of cGMP analogs
on corticostriatal EPSCs were similar in direct pathway SPNs
(dSPNs) and indirect pathway SPNs (iSPNs) (Figure 1F), consis-
tent with the broad striatal distribution of signaling molecules in
the NO pathway (Bredt et al., 1990; Vincent, 1994).
Because activation of the NO/cGMP/PKG pathway has been
shown to augment the activity of cholinergic interneurons (Cen-
tonze et al., 2001), the effect of SNAP was examined in theorts 13, 1336–1342, November 17, 2015 ª2015 The Authors 1337
Figure 2. NO-Producing Interneurons Can
Induce NO-LTD
(A) Simplified diagram depicting the experimental
design used to optogenetically probe PLTSI
involvement in NO-LTD.
(B) Full-field LED activation of PLTSIs for 5 min at
15 Hz induced NO-LTD at corticostriatal synapses
in SPNs synaptically coupled to PLTSIs. Example
traces are shown to the right.
(C) LTD was blocked by continuous bath
application of the nNOS inhibitor L-NAME (100 mM)
or inclusion of Rp8Br (3 mM) in the patch pipette
(control: n = 5; L-NAME: n = 6; Rp8Br: n = 5).
Example EPSCs are shown at right.
(D) Summary data for NO-LTD induced by PLTSI
activation. SPNs not coupled to PLTSIs showed no
response to the PLTSI stimulation paradigm (n = 4).
Data are presented as median, first and third quar-
tiles, minimum and maximum of data (whiskers).
**p < 0.01, Mann-Whitney nonparametric test.
(B and C) Population data are presented as median
and first and third quartiles.
Scale bars in (B) and (C) represent 20 pA, 10 ms.presence of antagonists of cholinergic signaling. Perfusion of the
nicotinic receptor antagonist mecamylamine (10 mM) and the
muscarinic receptor antagonist scopolamine (10 mM) prior to
and throughout SNAP perfusion did not alter the depression of
corticostriatal EPSCs (Figure 1G).
To rule out any effects of cellular dialysis with the patch elec-
trode, experiments using SNAP and 8Br-cGMP were also per-
formed in the perforated patch recording configuration. The
responses observed were similar to those seen in whole cells
(Figure S1C). Because the NO-induced reduction in evoked
EPSC amplitude persisted for as long as recordings could be
maintained, it will be referred to as NO-LTD.
Optogenetic Activation of PLTS Interneurons Induced
NO-LTD
Although the effects of SNAP and cGMP analogs were consis-
tent and robust, this does not prove that NO signaling is engaged
by the striatal circuitry to control synaptic strength (Feelisch,
1998). In the striatum, neuronal nitric oxide synthase (nNOS) is
expressed robustly only in interneurons that co-express somato-
statin, neuropeptide Y, and gamma amino butyric acid (GABA)
(Tepper et al., 2010). Because of their distinctive physiological
properties, these cells also are referred to as persistent and
low threshold spiking interneurons (PLTSIs). If NO is a bona
fide modulator of plasticity, the activation of PLTSIs and their1338 Cell Reports 13, 1336–1342, November 17, 2015 ª2015 The Authorsgeneration of NO should induce NO-LTD.
To test this hypothesis, we used opto-
genetic methods to selectively express
channelrhodopsin2 (ChR2) in striatal
PLTSIs (Holley et al., 2015; Witten et al.,
2011; Zhang et al., 2006) (Figures 2A and
S2A). In ex vivo brain slices from these
mice, SPNs were sorted into two groups:
those in which full-field optogenetic stimu-
lation of PLTSIs evoked GABAergic re-sponses (coupled) and those that showed no response (no
coupling) (Figure S2B). In SPNs coupled to PLTSIs, optical stim-
ulation for 5 min at 15 Hz, a firing frequency that spontaneously
active PLTSIs do not normally achieve in slice, led to a robust
LTD at corticostriatal synapses (Figures 2B and S2C). Exciting
PLTSIs to firing frequencies lower than 15 Hz, or stimulating for
shorter durations, failed to elicit LTD (Figure S2D). As expected,
when the nNOS inhibitor NG-nitro-L-arginine methyl ester
(L-NAME, 100 mM) or the PKG inhibitor Rp8Br (3 mM)was applied
throughout the recording period, LTD induction was blocked
(Figure 2C and 2D). Similarly, pre-incubation of slices with
SNAP occluded PLTS induction of LTD (Figure S2E). In contrast,
in SPNs where optical stimulation failed to evoke GABAergic
responses (possibly because optical stimulation was ineffective
in activating PLTSIs), the same stimulation protocol had no effect
on corticostriatal synaptic transmission (Figures 2D and S2B).
Taken together, these data argue that NO signaling originating
from PLTSIs induces LTD at corticostriatal synapses.
NO-LTD Was Independent of eCb Signaling and
Expressed Post-synaptically
Phenomenologically, the LTD induced by NO signaling (NO-LTD)
was very similar to that induced by eCb signaling (eCb-LTD).
However, the two forms of LTD had very different determinants.
First, NO-LTD induced by cGMP analogs in iSPNs and dSPNs
Figure 3. NO-LTD Is Post-synaptically
Expressed
(A) 8-Br-cGMP (500 mM) induced NO-LTD that was
blocked by intracellular application of the endo-
cytosis-disrupting peptide D15 (1–2 mM; control:
black trace, n = 6; D15: red trace, n = 6).
(B) Quantification of the population data shown in
(A). A scrambled peptide (sD15) had no effect on
8-Br-cGMPNO-LTD (1–2mM; n = 6). As expected,
sD15 did not disrupt LTD induced by DHPG
(100 mM; n = 6). *p < 0.05, signed rank test.
(C) Simplified diagram illustrating two-photon laser
uncaging of glutamate (2PLUG) experiments.
(D) Representative two-photon laser scanning
microscopy image of iSPN dendritic spine at which
2PLUG was performed (blue circle).
(E) 8-Br-cGMP induced a long-lasting decrease
in uEPSC amplitude. Example uEPSCs before
(pre-inc) and after transient bath application of
8-Br-cGMP (500 mM) are shown to the right. Time-
matched control traces (no 8-Br-cGMP applica-
tion; post-control) are shown for comparison. *p <
0.05, signed rank test.
(F) Summary data for the effect of 8Br-cGMP in
SPN dendritic spines (8-Br-cGMP: n = 26 spines, 5
cells; control: n = 29 spines, 3 cells). Data are
presented as median, first and third quartiles, and
minimum and maximum (whiskers).
(A and E) Data are presented as median and first
and third quartiles.
Scale bars represent 3 mm (D), 3 pA (E, right panel,
top), and 5 pA, 50 ms (E, right panel, bottom).was unaffected by antagonizing D2 dopamine receptors with
sulpiride (1 mM) (Figure S3A). Second, NO-LTD induced by
cGMP analogs in iSPNs and dSPNs was unaffected by antago-
nizing CB1 eCb receptors with AM251 (2 mM) (Figure S3A). Third,
NO-LTD was unaffected by dialyzing neurons with the Ca2+che-
lator BAPTA (20 mM) (Figure S3B). Each of these interventions is
known to block eCb-LTD (Kreitzer and Malenka, 2008; Mathur
and Lovinger, 2012). Another difference between these forms
of plasticity was that NO-LTD was readily induced at thalamos-
triatal glutamatergic synapses, in contrast to eCb-LTD (Wu et al.,
2015) (Figures S3C and S3D).
One of themost important features of eCb-LTD is thatwhile it is
induced post-synaptically in SPNs, it is expressed pre-synapti-
cally as a reduction in glutamate release probability (Kreitzer
and Malenka, 2008; Mathur and Lovinger, 2012). Four observa-
tions support the proposition that unlike eCb-LTD, NO-LTD
was expressed post-synaptically. First, the expression of NO-
LTD was not accompanied by a change in paired-pulse ratio,
a hallmark of pre-synaptic LTD (Figure S3E). Second, the
induction of NO-LTD was independent of pre-synaptic activity;
cessation of afferent fiber stimulation during the application of
8Br-cGMP had no effect on the magnitude of NO-LTD (Fig-
ure S3F), unlike eCb-LTD (Adermark et al., 2009). Third, intracel-
lular dialysis of D15—a polypeptide previously shown to disrupt
the interaction between dynamin and amphiphysin, which is
crucial for AMPAR endocytosis (Carroll et al., 1999; Morishita
et al., 2005)—blocked NO-LTD expression, while dialysis of a
scrambled peptide had no effect on NO-LTD (Figures 3A and
3B). Moreover, D15 dialysis did not alter eCb-LTD induced byCell Repthe metabotropic glutamate receptor agonist (S)-3,5-dihydroxy-
phenylglycine (DHPG; 100 mM) (Figure 3B). Fourth, transient
application of 8Br-cGMP persistently decreased the amplitude
of EPSCs evoked by uncaging of glutamate at visualized SPN
spines (Figures 3C–3F). Taken together, these results provide
strong evidence for a post-synaptic locus of NO-LTDexpression,
contrasting it with other forms of LTD described in the striatum.
NO Signaling Blocked eCb-LTD Induction
Are NO-LTD and eCb-LTD completely independent? As shown
above, NO-LTD does not depend upon signaling events (e.g.,
CB1R or D2R activation) known to be necessary for induction
of eCb-LTD. But could NO signaling blunt eCb-LTD? This would
help to explain why the two forms of LTD have not been distin-
guished to date. The core mechanisms controlling eCb-LTD
are well described, making pursuit of this aim tractable
(Figure 4A) (Mathur and Lovinger, 2012). As a first step toward
characterizing their interaction, NO-LTD was induced by SNAP
(100 mM) and a positive allosteric modulator of sGC (BAY-
41-2272, 10 mM) (Stasch et al., 2001); BAY-41-2272 was used
because it potentiated the ability of SNAP to induce LTD, was in-
hibited by Rp8Br and had no effect on its own (Figures S4A and
S4B) (Stasch et al., 2001). SPNs were then held at 50 mV,
afferent fibers stimulated at low frequency, and the mGluR
agonist DHPG (100 mM) applied; normally, this is a very robust
means of inducing eCb-LTD (Mathur and Lovinger, 2012; Surme-
ier et al., 2009) (Figure 4B). However, in this situation, the proto-
col failed to induce a lasting change in EPSC amplitude (Fig-
ure 4B), arguing that NO-LTD blocked eCb-LTD induction.orts 13, 1336–1342, November 17, 2015 ª2015 The Authors 1339
Figure 4. NO Signaling Occludes eCb-LTD through L-type Current Inhibition
(A) Simplified diagram outlining the mechanisms behind eCb-LTD.
(B) Induction of eCb-LTD by DHPG (100 mM; black trace, n = 6) was prevented by SNAP (100 mM) and BAY-41 (10 mM) perfused 10 min before and throughout
recording (red trace: n = 8). *p < 0.05, rank sum test. Example EPSCs are shown to the right.
(C) LTD induced by pharmacological activation of pre-synaptic CB1 receptors with WIN (2 mM) was not blocked by SNAP/BAY-41 (n = 7). *p < 0.05, signed rank
test.
(D) Two-photon laser scanning microscopy images of an iSPN (left) and dendritic spine from which a Ca2+ imaging line scan (middle, blue line) was performed.
Bath application of SNAP/BAY-41 reduced peak calcium influx (n = 26 spines, 3 cells). This reduction was occluded in the presence of 5 mM isradipine (n = 22
spines, 3 cells).
(E) Quantification of (D). *p < 0.05, signed rank test. Data are presented as median, first, and third quartiles, and minimum and maximum of data (whiskers).
(F) Integrated diagram depicting the interaction between eCb and NO-LTD.
(B and C) Data are presented as median and first and third quartiles.
Scale bars represent 20 pA, 25 ms (B); 40 pA, 20 ms (C); 20 mm (D, left), 3 mm (D, middle), and 4%DF/Fo and 200 ms (D, right).Bath application of 8Br-cGMP had a very similar effect, disrupt-
ing eCb-LTD (Figure S4C). The ability of NO signaling to disrupt
eCb-LTD was not pre-synaptic in origin as direct application of
the CB1R agonist WIN55,212-2mesylate (WIN) induced a robust
LTD in the presence of SNAP and BAY-41-2272 (Figure 4C). The
other possibility is that NO signaling blunted eCb generation. The
production of eCbs by SPNs requires the opening of L-type
Ca2+channels and an elevation in intracellular Ca2+concentration
(Mathur and Lovinger, 2012). In endocrine cells, phosphorylation
of L-type channels by PKG decreases their opening (Mahapatra
et al., 2012), raising the possibility that NO signaling was sup-
pressing dendritic L-type channels required for sustained eCb
synthesis. Indeed, co-application of SNAP (100 mM) and BAY-
41-2272 (10 mM) decreased SPN intraspine Ca2+ transients
evoked by somatic depolarization (Figure 4D and 4E). Antago-
nism of L-type channels with isradipine eliminated the effects
of SNAP/BAY on intraspine Ca2+ transients, confirming the
L-type specificity of the modulation (Figure 4D). Thus, NO
signaling disrupted the induction of eCb-LTD at least in part
by attenuating activity-dependent, post-synaptic Ca2+ entry
through L-type channels (Figure 4F).1340 Cell Reports 13, 1336–1342, November 17, 2015 ª2015 The AuDISCUSSION
The data presented make the case that NO release by PLTSIs
induces a post-synaptically expressed form of LTD at SPN axo-
spinous glutamatergic synapses. Although common in other re-
gions of the brain (Garthwaite and Boulton, 1995; Ho¨lscher,
1997; Susswein et al., 2004), this is the first demonstration that
striatal SPNs manifest this form of plasticity, complementing
post-synaptically expressed LTP (Surmeier et al., 2009). Themo-
lecular mechanisms underlying NO-LTD remain to be fully eluci-
dated, but our results point clearly to AMPA receptor endocy-
tosis. Elsewhere, PKG, which was necessary for NO-LTD, is
known to regulate the activity of DARPP-32 and protein phos-
phatase 1, both of which have been implicated in phosphoryla-
tion of the GluA2 AMPAR subunit (Walaas et al., 2011).
How does the existence of NO-LTD change our understanding
of the striatal network? PLTSIs appear to be part of a cortico-
striatal feed-forward circuit that is activated in parallel with
SPNs (Tepper et al., 2010). Thus, NO-LTD could counterpoise
dopamine-dependent potentiation of glutamatergic synaptic
strength in SPNs during goal-based learning, helping to maintainthors
a stable level of regional responsiveness by diminishing the
strength of inactive synapses neighboring those undergoing
potentiation. For this mechanism to work, the signaling mecha-
nisms governing LTP induction would have to oppose those of
NO-LTD. As Ca2+ entry through NMDA receptors is necessary
for LTP induction in SPNs (Shen et al., 2008), phosphodiesterase
1, a striatally enriched, Ca2+/calmodulin-dependent phosphodi-
esterase that preferentially degrades cGMP, might mediate this
interaction (Bender and Beavo, 2006). An additional possibility
may be that NO released from PLTSIs also simultaneously tunes
GABAergic inputs within the striatum, specifically from other in-
terneurons onto SPNs, a possibility that has been described
elsewhere (Nugent et al., 2007; Sagi et al., 2014).
In disease states, deficits in NO-LTD could contribute to patho-
logical remodeling of the striatal circuitry. For example, in models
of Parkinson’s disease (PD), striatal NO signaling falls (Sancesario
et al., 2004). The loss of feed-forwardNO-LTD could contribute to
hyperactivity of iSPNs and hypokinetic symptoms of the disease
(Albin et al., 1989). The sustained elevation in iSPN activity ap-
pears to drive profound homeostatic pruning of corticostriatal
synapses (Day et al., 2006; Fieblinger et al., 2014), disrupting pat-
terns of connectivity shaped by experience. An impairment inNO-
LTD might also contribute to levodopa-induced strengthening of
dSPN corticostriatal synapses and dyskinesia in PD (Picconi
et al., 2011). How pathological changes in NO signaling preferen-
tially effect dSPNs and iSPNs requires further study.
EXPERIMENTAL PROCEDURES
Tissue Preparation
All experiments were performed in accordance with the Northwestern Univer-
sity Animal Care and Use Committee and NIH guidelines. 6- to 12-week-old
male hemizygous C57Bl/6 mice expressing EGFP under control of either the
Drd1a or Drd2 receptor regulatory elements; Thy1-ChR2 mice; SST-IRES-
Cre mice (Ssttm2.1(cre)Zjh/J), and KH288 mice developed by the GENSAT
Project were used. Mice were killed by decapitation and the brain removed
in artificial cerebral spinal fluid (ACSF). Para-sagittal brain slices containing
striatum were cut at 275–300 mM, and slices were incubated in 30C–33C
ACSF until recording.
Electrophysiology
After incubation, slices were transferred to a recording chamber perfused with
oxygenated ACSF at 30C–33C. Cells were filled with a Cs-based internal.
SPNswere voltage-clamped at70mV and stimuli delivered at 0.1 Hz through
a concentric bipolar electrode placed in the cortex in the presence of 10 mM
gabazine to block GABAA currents. Optical stimuli were delivered through
the epifluorescent light path using an LED light source (CoolLED). Access
resistance was monitored throughout recording and cells in which there was
a change >20% of baseline were excluded.
Viral Gene Delivery
For optogenetic experiments, a cre-dependent AAV-ChR2 vector was injected
into the striatum or thalamus of SST-IRES-Cre or KH288-Cre mice, respec-
tively. Mice were sacrificed 2–3 weeks postinfection.
Two-Photon Laser Scanning Microscopy
iSPNs were identified by somatic EGFP expression. Following patch rupture,
the internal solution was allowed to equilibrate for 10–15 min before imaging.
Ca2+ Imaging
SPNs were loaded with 25 mMAlexa 568 and 600 mMFluo 5F via the recording
electrode, which contained a CsMeSO3 internal. Green fluorescent line-scanCell Repsignals were acquired from dendritic spines 200 ms before a 300-ms voltage
step from 70 to 0 mV. Changes in Fluo 5F fluorescence were measured as
DF/Fo.
Two-Photon Laser Uncaging of Glutamate
Glutamate uncaging was achieved using a Verdi/Mira laser system. 5 mM
MNI-glutamate was superfused over the slice at 0.4 ml/hr using a syringe
pump and multi-barreled perfusion manifold (Cell MicroControls). Glutamate
was uncaged adjacent to individual spines using 1-ms pulses of 725-nm light.
Photolysis power was tuned via a third Pockels cell modulator (Con Optics)
to achieve uncaged-EPSCs (uEPSCs) % 5 pA. uEPSC amplitudes were
measured from averaged (five repetitions) traces.
Chemical and Reagents
Rp-8-Br-PET-cGMPS was obtained from Biolog Life Science Institute,
L-NAME was obtained from Sigma Aldrich, and all other reagents were
obtained from Tocris. Custom peptides were synthesized by the Stanford
peptide facility and used at a concentration of 1–2 mM.
Data Analysis and Statistics
Themagnitude of LTDwas calculated as a percentage of the baseline (minutes
0–5 of recording time). Unless otherwise noted, the average of minutes 30–35
of each recording was used to calculate effects of drug application. Time se-
ries data are reported as median, first and third quartiles (whiskers), and out-
liers removed. Data reported in box plots represent the median, first and third
quartiles, and minimum and maximum of data (whiskers) with the outlier
removed. dSPNs and iSPNs were combined in datasets unless specified
(e.g., Figures 1E and 1F).
An extended description of the experimental procedures is included in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.10.015.
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